On one hand, our data raise the possibility that lung adenocarcinomas with higher expression of SLFN12 might behave in a less aggressive fashion, and thus might be amenable to less aggressive cytotoxic regimen. The gene discussed is SLFN12; the disease is lung adenocarcinoma.